Immune to Cancer: The CRI Blog




Patient Immunotherapy Summit: Lung Cancer Brief

Thomas Urban Marron, MD, PhD, Icahn School of Medicine at Mount Sinai and CRI Clinical Innovator, is an authority in the immunotherapy space with backgrounds both in research and medicine. CRI is proud to have him speak during this summit about lung cancer, a disease that is diagnosed in over 2M new patients every year worldwide. Dr. Marron contributes towards our greater understanding of lung cancer and novel treatments for the disease.

Read more:

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.